. . . . . . . . . . . . . . . . "composite(p(EGID:3082),a(CHEBI:cisplatin)) -| r(HGNC:RRM2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Genes modulated only in response to the combined treatment with HGF and CDDP, but not by the single treatment, are particularly interesting as they could be better relatedtoHGF-mediated sensitization toCDDP. In fact, this is a distinctive response of ovarian cancer cells as shown in several ovarian cancer cell lines (8, 11). In this group, those above all down-modulated were PANK3, RAMP, RRM2, and TDG. Most of them have been already associated to cell proliferation and apoptosis and even to cancer cell resistance" . . "Selventa" . . . . "2014-07-03T14:30:43.345+02:00"^^ . . .